Regeneron shares fall after FDA rejects high-dose eye disease treatment
Regeneron said the rejection was “solely due to an ongoing review of inspection findings at a third-party filler.”
More than $200 billion in Covid loans potentially stolen by fraudsters, watchdog says
More than $200 billion in Covid aid disbursed by the Small Business Administration may have been stolen, a federal watchdog said.
Severe weather, FAA shortfalls kick off rocky start to summer air travel
United’s CEO blamed FAA staffing shortages for worsening flight disruptions over the weekend.
Unity shares rise 15% after company announces A.I. marketplace
AI companies will be able to distribute their software to game makers and charge for it through Unity’s Asset Store.
Chicago business executive and philanthropist Jim Crown killed in Colorado racetrack crash
Jim Crown, a Chicago executive and philanthropist, died Sunday in a car crash on a racing track in Colorado.
Baupost Group’s Seth Klarman found the next ‘hunting ground’ for value investors
The hedge fund investor said ‘there might be opportunities to buy’ as real estate comes under more pressure.
Walgreens slashes earnings guidance due to lower consumer spending, drop in Covid care demand
CEO Rosalind Brewer said Walgreens will increase its cost-cutting program to $4.1 billion and take action to increase profitability in the health-care segment.
Delta lifts profit forecast thanks to strong demand and premium tickets
Delta said consumers continue to book and trade up to more expensive cabins.
Microsoft CEO Satya Nadella set goal of $500 billion in revenue by 2030, court filing shows
A court filing released on Monday showed that last year Microsoft CEO Satya Nadella provided a goal for his company’s top-line financials through 2030.
Eli Lilly experimental obesity drug could beat rivals in total weight loss for patients
Obese or overweight patients who took Eli Lilly’s retatrutide lost 58 pounds on average, the pharmaceutical company said in a mid-stage clinical trial.
